Skip to Main Content

Paper Details

Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes.
JAMA Oncol
49
2022
ATM, ATM variants, BARD1, BARD1 variants, BC, BC genes, BRCA1, BRCA2, BRCA2 and PALB2 variants, Breast Cancer, Breast Cancer Susceptibility Genes, CHEK2, CHEK2 variants, ERBB2, ERBB2+, HER2, HR, HR+ERBB2+ and HR-ERBB2+ subtypes, PALB2, PALB2 variants, RAD51C, RAD51D, TP53, TP53 variants, Tumors, breast cancer, estrogen, estrogen receptor, gene, gene panel, germline, high-grade subtype, hormone receptor, participants, pathogenic variant, patients, progesterone, progesterone receptor, triple, triple-negative disease, triple-negative tumors, tumor, tumors, women
Author NameAffiliation
Irene L AndrulisFred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital
Irene L AndrulisUniversity of Toronto
Irene L AndrulisFred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital
Irene L AndrulisUniversity of Toronto
Sabine BehrensGerman Cancer Research Center
Javier Ben??tezSpanish National Cancer Research Centre
Javier Ben??tez
Jenny Chang-ClaudeGerman Cancer Research Center
Jenny Chang-ClaudeUniversity Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf
Stephen J ChanockNational Cancer Institute, National Institutes of Health
Stephen J ChanockNational Cancer Institute, National Institutes of Health
Georgia Chenevix-TrenchQIMR Berghofer Medical Research Institute
Georgia Chenevix-TrenchQIMR Berghofer Medical Research Institute
Peter A FaschingComprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg
Peter A FaschingDavid Geffen School of Medicine, University of California at Los Angeles.
Jonine D FigueroaUniversity of Edinburgh
Jonine D FigueroaUniversity of Edinburgh
Jonine D FigueroaUniversity of Edinburgh
Jonine D FigueroaUniversity of Edinburgh
Graham G Giles
Graham G GilesSchool of Clinical Sciences at Monash Health, Monash University
Graham G GilesThe University of Melbourne
Per HallKarolinska Institutet
Per Hall
Vessela N KristensenOslo University Hospital and University of Oslo
Vessela N KristensenUniversity of Oslo
Jan LubinskiPomeranian Medical University
Jan LubinskiPomeranian Medical University
Roger L Milne
Roger L MilneSchool of Clinical Sciences at Monash Health, Monash University
Roger L MilneThe University of Melbourne
Ana OsorioSpanish National Cancer Research Centre
Ana Osorio
Paolo RadiceFondazione IRCCS Istituto Nazionale dei Tumori
Xueling SimSaw Swee Hock School of Public Health, National University of Singapore and National University Health System
Heather ThornePeter MacCallum Cancer Center
Heather ThorneUniversity of Melbourne
Amanda B SpurdleQIMR Berghofer Medical Research Institute
Amanda B SpurdleQIMR Berghofer Medical Research Institute
Alison M DunningUniversity of Cambridge
Montserrat Garcia-ClosasNational Cancer Institute, National Institutes of Health
Montserrat Garcia-ClosasNational Cancer Institute, National Institutes of Health
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Douglas F EastonUniversity of Cambridge
Douglas F EastonUniversity of Cambridge
  • 1 - 48

Datasets